Remove tag economic-impact
article thumbnail

Cost of disease-modifying therapies for multiple sclerosis continues to rise in US

Pharmaceutical Technology

While MS is not a terminal diagnosis, the effect of the disease on the CNS can significantly impact patients’ independence and disturb their daily lives. However, they cannot provide a cure and have a very limited impact on halting disease progression. DMTs for MS have a high price tag, particularly in the US.

article thumbnail

[Podcast] COVID Disruption & Its Indelible Mark on Healthcare Marketing

Healthcare Success

"Even though COVID's in a much better place in terms of serious impact, it's still here, making it impossible for [healthcare] systems to recover," Alan explains. "We We discussed our personal experiences with COVID and how it impacted our short- and long-term health. COVID’s Economic Impact on Health Systems.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Upcoming sickle cell gene therapies cost effective at $2 million, says ICER

Pharmaceutical Technology

Two gene therapies up for approval this year for sickle cell disease could be cost effective in some cases at a $2 million price point, based on a draft evidence report published by the Institute for Clinical and Economic Review (ICER).

article thumbnail

How automation can help to address supply chain challenges in pharma

pharmaphorum

Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products.

Pharma 101
article thumbnail

Q&A: A decade on, what’s next for CAR-T therapies?

Pharmaceutical Technology

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. There are issues of geography, but also issues of economics. Currently, all approved CAR-T therapies are autologous, where T cells taken from patients are modified and then re-infused.

article thumbnail

Healthcare Marketing to Seniors: How to Create and Distribute on-Target Messaging

Healthcare Success

“As the largest generational group in US history (until the millennial generation slightly surpassed them), baby boomers have had—and continue to have—a significant impact on the economy. They’re credited as one of the wealthiest generations to date and are still economically powerful despite their old age.”. Baby boomers hold $2.6

article thumbnail

CSL doses first patient with haemophilia B gene therapy Hemgenix

Pharmaceutical Technology

The high price tag may be hard to defend , but with lifetime treatment costs for haemophilia B reaching as high as $23m for some, the single-dose treatment could prove far more cost-effective. Despite this, the Institute for Clinical and Economic Review (ICER) claimed that a fairer price would be in the region of $2.9m.